Shindo et al identified risk factors associated with community-acquired or healthcare-associated pneumonia (CAP or HCAP) with a drug-resistant pathogen. These can help to identify a patient who may require more aggressive management. The authors are from multiple hospitals in Japan participating in the Central Japan Lung Study Group.